Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Effects of FSAE in rabbits (n by Houkang Ding (20968091)

Interaction profile of targeted receptor molecules and orientin. by Yashwanth Elumalai (21743452)

OPLS-DA score plot and volcano plot in the control and diarrhea groups. by Houkang Ding (20968091)

Diverse regulatory gate forms. by Jeong-Soo Gim (18058588)

Fourier Transform Infra-Red Spectroscopy (FT-IR) of Native Orientin and NF-Orientin. by Yashwanth Elumalai (21743452)

Synthesis preparation of nano-formulated orientin by using solvent evaporation method. by Yashwanth Elumalai (21743452)

UV-Spectrophotometer of Native Orientin and NF-Orientin. by Yashwanth Elumalai (21743452)

Illustrates the schematic representation of <i>in ova</i> experimentation showing with timeline. by Yashwanth Elumalai (21743452)

The results of self-organising map (SOM) clustering. by Jeong-Soo Gim (18058588)

Microscopic pictorial representation of wound healing assay (Control, native orientin (NF) and NF-O in 0 h and 24 h). by Yashwanth Elumalai (21743452)

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

H& E staining investigation of CAM treated with native-orientin (5 μM), native-orientin (10 μM), NF-O (5 μM), and NF-O (10 μM). by Yashwanth Elumalai (21743452)

The effect of preservative treatments on average percentages of high molecular weight DNA (%HMW) and average yields of high molecular weight DNA normalized by tissue weight (nY) fo... by Ella Messner (14493059)

Data Sheet 1_Neuronal expression of S100B triggered by oligomeric Aβ peptide contributes to protection against cytoskeletal damage and synaptic loss.docx by Joana Saavedra (11327910)

“…We used the AD mouse model AβPPswe/PS1A246E to show that neuronal S100B levels are significantly higher in 10-month-old animals, and cellular assays to demonstrate that Aβ oligomers significantly increase S100B expression in SH-SY5Y cells, but not monomeric or fibrillar Aβ. …”